The University of Chicago Header Logo

Connection

Anita Chong to Mice

This is a "connection" page, showing publications Anita Chong has written about Mice.
Connection Strength

2.641
  1. CAR Treg synergy with anti-CD154 promotes infectious tolerance and dictates allogeneic heart transplant acceptance. JCI Insight. 2025 Apr 08; 10(7).
    View in: PubMed
    Score: 0.084
  2. Pregnancy dedifferentiates memory CD8+ T cells into hypofunctional cells with exhaustion-enriched programs. JCI Insight. 2024 May 21; 9(13).
    View in: PubMed
    Score: 0.079
  3. MHC Tetramers Specifically Identify High- and Low-avidity Donor-specific B Cells in Transplantation Tolerance and Rejection. Transplantation. 2023 12 01; 107(12):2526-2532.
    View in: PubMed
    Score: 0.076
  4. Lung cDC1 and cDC2 dendritic cells priming naive CD8+ T cells in situ prior to migration to draining lymph nodes. Cell Rep. 2023 10 31; 42(10):113299.
    View in: PubMed
    Score: 0.076
  5. A novel triptolide analog downregulates NF-?B and induces mitochondrial apoptosis pathways in human pancreatic cancer. Elife. 2023 10 25; 12.
    View in: PubMed
    Score: 0.076
  6. Beyond Adaptive Alloreactivity: Contribution of Innate B Cells to Allograft Inflammation and Rejection. Transplantation. 2023 01 01; 107(1):98-104.
    View in: PubMed
    Score: 0.071
  7. From bench to bedside: reversing established antibody responses and desensitization. Curr Opin Organ Transplant. 2022 10 01; 27(5):376-384.
    View in: PubMed
    Score: 0.070
  8. Linked sensitization by memory CD4+ T cells prevents costimulation blockade-induced transplantation tolerance. JCI Insight. 2022 06 08; 7(11).
    View in: PubMed
    Score: 0.069
  9. Pregnancy-induced humoral sensitization overrides T cell tolerance to fetus-matched allografts in mice. J Clin Invest. 2021 01 04; 131(1).
    View in: PubMed
    Score: 0.062
  10. Transplantation tolerance modifies donor-specific B cell fate to suppress de novo alloreactive B cells. J Clin Invest. 2020 07 01; 130(7):3453-3466.
    View in: PubMed
    Score: 0.060
  11. B cells as antigen-presenting cells in transplantation rejection and tolerance. Cell Immunol. 2020 03; 349:104061.
    View in: PubMed
    Score: 0.059
  12. Evolving Approaches in the Identification of Allograft-Reactive T and B Cells in Mice and Humans. Transplantation. 2017 11; 101(11):2671-2681.
    View in: PubMed
    Score: 0.050
  13. Transplantation tolerance: don't forget about the B cells. Clin Exp Immunol. 2017 08; 189(2):171-180.
    View in: PubMed
    Score: 0.048
  14. Erosion of Transplantation Tolerance After Infection. Am J Transplant. 2017 01; 17(1):81-90.
    View in: PubMed
    Score: 0.046
  15. Delayed Cytotoxic T Lymphocyte-Associated Protein 4-Immunoglobulin Treatment Reverses Ongoing Alloantibody Responses and Rescues Allografts From Acute Rejection. Am J Transplant. 2016 08; 16(8):2312-23.
    View in: PubMed
    Score: 0.045
  16. Cutting Edge: CTLA-4Ig Inhibits Memory B Cell Responses and Promotes Allograft Survival in Sensitized Recipients. J Immunol. 2015 Nov 01; 195(9):4069-73.
    View in: PubMed
    Score: 0.043
  17. Spontaneous restoration of transplantation tolerance after acute rejection. Nat Commun. 2015 Jul 07; 6:7566.
    View in: PubMed
    Score: 0.043
  18. Titrating T-cell epitopes within self-assembled vaccines optimizes CD4+ helper T cell and antibody outputs. Adv Healthc Mater. 2014 Nov; 3(11):1898-908.
    View in: PubMed
    Score: 0.040
  19. Lessons and limits of mouse models. Cold Spring Harb Perspect Med. 2013 Dec 01; 3(12):a015495.
    View in: PubMed
    Score: 0.038
  20. Reversing endogenous alloreactive B cell GC responses with anti-CD154 or CTLA-4Ig. Am J Transplant. 2013 Sep; 13(9):2280-92.
    View in: PubMed
    Score: 0.037
  21. Enhancing pancreatic Beta-cell regeneration in vivo with pioglitazone and alogliptin. PLoS One. 2013; 8(6):e65777.
    View in: PubMed
    Score: 0.037
  22. Experimental models of B cell tolerance in transplantation. Semin Immunol. 2012 Apr; 24(2):77-85.
    View in: PubMed
    Score: 0.033
  23. IL-6 induced by Staphylococcus aureus infection prevents the induction of skin allograft acceptance in mice. Am J Transplant. 2011 May; 11(5):936-46.
    View in: PubMed
    Score: 0.032
  24. Alloantibodies prevent the induction of transplantation tolerance by enhancing alloreactive T cell priming. J Immunol. 2011 Jan 01; 186(1):214-21.
    View in: PubMed
    Score: 0.031
  25. Infection with the intracellular bacterium, Listeria monocytogenes, overrides established tolerance in a mouse cardiac allograft model. Am J Transplant. 2010 Jul; 10(7):1524-33.
    View in: PubMed
    Score: 0.030
  26. Seeing is believing: how the MIP-luc mouse can advance the field of islet transplantation and ß-cell regeneration. Islets. 2010 Jul-Aug; 2(4):261-2.
    View in: PubMed
    Score: 0.030
  27. Glycemic control promotes pancreatic beta-cell regeneration in streptozotocin-induced diabetic mice. PLoS One. 2010 Jan 18; 5(1):e8749.
    View in: PubMed
    Score: 0.029
  28. Memory alloreactive B cells and alloantibodies prevent anti-CD154-mediated allograft acceptance. J Immunol. 2009 Feb 01; 182(3):1314-24.
    View in: PubMed
    Score: 0.027
  29. Prevention of allograft tolerance by bacterial infection with Listeria monocytogenes. J Immunol. 2008 May 01; 180(9):5991-9.
    View in: PubMed
    Score: 0.026
  30. Long-term control of alloreactive B cell responses by the suppression of T cell help. J Immunol. 2008 May 01; 180(9):6077-84.
    View in: PubMed
    Score: 0.026
  31. Hyperacute rejection by anti-Gal IgG1, IgG2a, and IgG2b is dependent on complement and Fc-gamma receptors. J Immunol. 2008 Jan 01; 180(1):261-8.
    View in: PubMed
    Score: 0.025
  32. Expression of complement regulatory proteins in accommodated xenografts induced by anti-alpha-Gal IgG1 in a rat-to-mouse model. Am J Transplant. 2008 Jan; 8(1):32-40.
    View in: PubMed
    Score: 0.025
  33. Peripheral deletion of mature alloreactive B cells induced by costimulation blockade. Proc Natl Acad Sci U S A. 2007 Jul 17; 104(29):12093-8.
    View in: PubMed
    Score: 0.024
  34. Recovery of islet beta-cell function in streptozotocin- induced diabetic mice: an indirect role for the spleen. Diabetes. 2006 Dec; 55(12):3256-63.
    View in: PubMed
    Score: 0.024
  35. TLR engagement prevents transplantation tolerance. Am J Transplant. 2006 Oct; 6(10):2282-91.
    View in: PubMed
    Score: 0.023
  36. Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration. Science. 2006 Mar 24; 311(5768):1774-5.
    View in: PubMed
    Score: 0.022
  37. Liver ischemia contributes to early islet failure following intraportal transplantation: benefits of liver ischemic-preconditioning. Am J Transplant. 2006 Jan; 6(1):60-8.
    View in: PubMed
    Score: 0.022
  38. Follicular regulatory T cells restrain kidney allograft rejection in mice by suppressing alloreactive B cells. Nat Commun. 2025 Mar 04; 16(1):2151.
    View in: PubMed
    Score: 0.021
  39. Isolation and transcriptional profiling of antigen-presenting cells from mouse lung and MLNs following intranasal immunization. STAR Protoc. 2024 12 20; 5(4):103400.
    View in: PubMed
    Score: 0.020
  40. Cutting Edge: NK cells mediate IgG1-dependent hyperacute rejection of xenografts. J Immunol. 2004 Jun 15; 172(12):7235-8.
    View in: PubMed
    Score: 0.020
  41. Low-affinity CD8+ T cells provide interclonal help to high-affinity CD8+ T cells to augment alloimmunity. Am J Transplant. 2024 Jun; 24(6):933-943.
    View in: PubMed
    Score: 0.019
  42. Advancing mouse models for transplantation research. Am J Transplant. 2024 Aug; 24(8):1362-1368.
    View in: PubMed
    Score: 0.019
  43. Heterogeneity in allospecific T cell function in transplant-tolerant hosts determines susceptibility to rejection following infection. J Clin Invest. 2023 11 01; 133(21).
    View in: PubMed
    Score: 0.019
  44. IL-21-producing effector Tfh cells promote B cell alloimmunity in lymph nodes and kidney allografts. JCI Insight. 2023 10 23; 8(20).
    View in: PubMed
    Score: 0.019
  45. Donor programmed cell death 1 ligand 1 is required for organ transplant tolerance in major histocompatibility complex-mismatched mixed chimeras although programmed cell death 1 ligand 1 and major histocompatibility complex class II are not required for inducing chimerism. Am J Transplant. 2023 08; 23(8):1116-1129.
    View in: PubMed
    Score: 0.018
  46. The in vitro and in vivo effects of anti-galactose antibodies on endothelial cell activation and xenograft rejection. J Immunol. 2003 Feb 01; 170(3):1531-9.
    View in: PubMed
    Score: 0.018
  47. IFN-gamma production is specifically regulated by IL-10 in mice made tolerant with anti-CD40 ligand antibody and intact active bone. J Immunol. 2003 Jan 15; 170(2):853-60.
    View in: PubMed
    Score: 0.018
  48. Role of CD4+ and CD8+ T cells in the rejection of concordant pancreas xenografts. Transplantation. 2002 Nov 15; 74(9):1236-41.
    View in: PubMed
    Score: 0.018
  49. Transcriptionally Distinct B Cells Infiltrate Allografts After Kidney Transplantation. Transplantation. 2023 02 01; 107(2):e47-e57.
    View in: PubMed
    Score: 0.018
  50. Reduced Satb1 expression predisposes CD4+ T conventional cells to Treg suppression and promotes transplant survival. Proc Natl Acad Sci U S A. 2022 10 04; 119(40):e2205062119.
    View in: PubMed
    Score: 0.018
  51. Host-versus-commensal immune responses participate in the rejection of colonized solid organ transplants. J Clin Invest. 2022 09 01; 132(17).
    View in: PubMed
    Score: 0.018
  52. Allograft tolerance induced by intact active bone co-transplantation and anti-CD40L monoclonal antibody therapy. Transplantation. 2002 Aug 15; 74(3):345-54.
    View in: PubMed
    Score: 0.017
  53. Tissue specificity drives protective immunity against Staphylococcus aureus infection. Front Immunol. 2022; 13:795792.
    View in: PubMed
    Score: 0.017
  54. Acute xenograft rejection mediated by antibodies produced independently of TH1/TH2 cytokine profiles. Am J Transplant. 2002 Jul; 2(6):526-34.
    View in: PubMed
    Score: 0.017
  55. Oral alloantigen exposure promotes donor-specific tolerance in a mouse model of minor-mismatched skin transplantation. Am J Transplant. 2022 10; 22(10):2348-2359.
    View in: PubMed
    Score: 0.017
  56. Intact active bone transplantation synergizes with anti-CD40 ligand therapy to induce B cell tolerance. J Immunol. 2002 May 15; 168(10):5352-8.
    View in: PubMed
    Score: 0.017
  57. CTLA-41g in combination with anti-CD40L prolongs xenograft survival and inhibits anti-gal ab production in GT-Ko mice. Am J Transplant. 2002 Jan; 2(1):41-7.
    View in: PubMed
    Score: 0.017
  58. Innate-like self-reactive B cells infiltrate human renal allografts during transplant rejection. Nat Commun. 2021 07 16; 12(1):4372.
    View in: PubMed
    Score: 0.016
  59. Lewis rat pancreas, but not cardiac xenografts, are resistant to anti-gal antibody mediated hyperacute rejection. Transplantation. 2001 May 27; 71(10):1385-9.
    View in: PubMed
    Score: 0.016
  60. Non-depleting anti-CD4, but not anti-CD8, antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha1,3-galactosyltransferase knockout (GT-Ko) mice. Xenotransplantation. 2000 Nov; 7(4):275-83.
    View in: PubMed
    Score: 0.015
  61. Anti-galactose-alpha(1,3)Galactose antibody production in alpha1, 3-galactosyltransferase gene knockout mice after xeno- and allotransplantation. Transplant Proc. 2000 Aug; 32(5):844-5.
    View in: PubMed
    Score: 0.015
  62. Efficacy of FK506, leflunomide, anti-CD4, and CTLA4IG treatments in rat to mouse pancreas xenograft transplantation. Transplant Proc. 2000 Aug; 32(5):1003-4.
    View in: PubMed
    Score: 0.015
  63. Nondepleting anti-CD4 but not anti-CD8 antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha1, 3-galactosyl-transferase knock-out mice. Transplant Proc. 2000 Aug; 32(5):1005.
    View in: PubMed
    Score: 0.015
  64. Anti-galactose-alpha(1,3) galactose antibody production in alpha1,3-galactosyltransferase gene knockout mice after xeno and allo transplantation. Transpl Immunol. 2000 Jun; 8(2):129-37.
    View in: PubMed
    Score: 0.015
  65. Reversing donor-specific antibody responses and antibody-mediated rejection with bortezomib and belatacept in mice and kidney transplant recipients. Am J Transplant. 2020 10; 20(10):2675-2685.
    View in: PubMed
    Score: 0.015
  66. Inhibition of protective immunity against Staphylococcus aureus infection by MHC-restricted immunodominance is overcome by vaccination. Sci Adv. 2020 04; 6(14):eaaw7713.
    View in: PubMed
    Score: 0.015
  67. Enabling sublingual peptide immunization with molecular self-assemblies. Biomaterials. 2020 05; 241:119903.
    View in: PubMed
    Score: 0.015
  68. Tolerance of T-independent xeno-antibody responses in the hamster-to-rat xenotransplantation model is species-restricted but not tissue-specific. Xenotransplantation. 2000 Feb; 7(1):48-57.
    View in: PubMed
    Score: 0.015
  69. Resilience of T cell-intrinsic dysfunction in transplantation tolerance. Proc Natl Acad Sci U S A. 2019 11 19; 116(47):23682-23690.
    View in: PubMed
    Score: 0.014
  70. In vitro and in vivo antitumor activity of a novel immunomodulatory drug, leflunomide: mechanisms of action. Biochem Pharmacol. 1999 Nov 01; 58(9):1405-13.
    View in: PubMed
    Score: 0.014
  71. Skin-restricted commensal colonization accelerates skin graft rejection. JCI Insight. 2019 07 16; 5.
    View in: PubMed
    Score: 0.014
  72. In vivo activity of leflunomide: pharmacokinetic analyses and mechanism of immunosuppression. Transplantation. 1999 Jul 15; 68(1):100-9.
    View in: PubMed
    Score: 0.014
  73. Distinct Graft-Specific TCR Avidity Profiles during Acute Rejection and Tolerance. Cell Rep. 2018 08 21; 24(8):2112-2126.
    View in: PubMed
    Score: 0.013
  74. Induction of species-specific host accommodation in the hamster-to-rat xenotransplantation model. J Immunol. 1998 Aug 15; 161(4):2044-51.
    View in: PubMed
    Score: 0.013
  75. In vitro and in vivo mechanisms of action of the antiproliferative and immunosuppressive agent, brequinar sodium. J Immunol. 1998 Jan 15; 160(2):846-53.
    View in: PubMed
    Score: 0.013
  76. Control of lymphoproliferative and autoimmune disease in MRL-lpr/lpr mice by brequinar sodium: mechanisms of action. J Pharmacol Exp Ther. 1997 Nov; 283(2):869-75.
    View in: PubMed
    Score: 0.013
  77. The IRF4 Gene Regulatory Module Functions as a Read-Write Integrator to Dynamically Coordinate T Helper Cell Fate. Immunity. 2017 09 19; 47(3):481-497.e7.
    View in: PubMed
    Score: 0.012
  78. The immunosuppressive metabolite of leflunomide, A77 1726, affects murine T cells through two biochemical mechanisms. J Immunol. 1997 Jul 01; 159(1):22-7.
    View in: PubMed
    Score: 0.012
  79. In vivo mechanism by which leflunomide controls lymphoproliferative and autoimmune disease in MRL/MpJ-lpr/lpr mice. J Immunol. 1997 Jul 01; 159(1):167-74.
    View in: PubMed
    Score: 0.012
  80. Self-Antigen-Driven Thymic B Cell Class Switching Promotes T Cell Central Tolerance. Cell Rep. 2016 10 04; 17(2):387-398.
    View in: PubMed
    Score: 0.012
  81. Vav in natural killer cells is tyrosine phosphorylated upon cross-linking of Fc gamma RIIIA and is constitutively associated with a serine/threonine kinase. Biochem J. 1996 Sep 01; 318 ( Pt 2):527-32.
    View in: PubMed
    Score: 0.012
  82. Two activities of the immunosuppressive metabolite of leflunomide, A77 1726. Inhibition of pyrimidine nucleotide synthesis and protein tyrosine phosphorylation. Biochem Pharmacol. 1996 Aug 23; 52(4):527-34.
    View in: PubMed
    Score: 0.012
  83. The composition of the microbiota modulates allograft rejection. J Clin Invest. 2016 07 01; 126(7):2736-44.
    View in: PubMed
    Score: 0.011
  84. Adoptive Transfer of Tracer-Alloreactive CD4+ T Cell Receptor Transgenic T Cells Alters the Endogenous Immune Response to an Allograft. Am J Transplant. 2016 10; 16(10):2842-2853.
    View in: PubMed
    Score: 0.011
  85. Tracking of TCR-Transgenic T Cells Reveals That Multiple Mechanisms Maintain Cardiac Transplant Tolerance in Mice. Am J Transplant. 2016 10; 16(10):2854-2864.
    View in: PubMed
    Score: 0.011
  86. High-Fat Diet-Induced Obesity Enhances Allograft Rejection. Transplantation. 2016 05; 100(5):1015-21.
    View in: PubMed
    Score: 0.011
  87. Proteomic Identification of saeRS-Dependent Targets Critical for Protective Humoral Immunity against Staphylococcus aureus Skin Infection. Infect Immun. 2015 Sep; 83(9):3712-21.
    View in: PubMed
    Score: 0.011
  88. Inhibition of protein tyrosine phosphorylation in T cells by a novel immunosuppressive agent, leflunomide. J Biol Chem. 1995 May 26; 270(21):12398-403.
    View in: PubMed
    Score: 0.011
  89. Gut microbiota elicits a protective immune response against malaria transmission. Cell. 2014 Dec 04; 159(6):1277-89.
    View in: PubMed
    Score: 0.010
  90. Gradated assembly of multiple proteins into supramolecular nanomaterials. Nat Mater. 2014 Aug; 13(8):829-36.
    View in: PubMed
    Score: 0.010
  91. Protective immunity against recurrent Staphylococcus aureus skin infection requires antibody and interleukin-17A. Infect Immun. 2014 May; 82(5):2125-34.
    View in: PubMed
    Score: 0.010
  92. The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation. Biomaterials. 2013 Nov; 34(34):8776-85.
    View in: PubMed
    Score: 0.009
  93. B cells assist allograft rejection in the deficiency of protein kinase c-theta. Transpl Int. 2013 Sep; 26(9):919-27.
    View in: PubMed
    Score: 0.009
  94. Local inflammation exacerbates the severity of Staphylococcus aureus skin infection. PLoS One. 2013; 8(7):e69508.
    View in: PubMed
    Score: 0.009
  95. Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4. Immunity. 2013 May 23; 38(5):918-29.
    View in: PubMed
    Score: 0.009
  96. A self-adjuvanting supramolecular vaccine carrying a folded protein antigen. Adv Healthc Mater. 2013 Aug; 2(8):1114-9.
    View in: PubMed
    Score: 0.009
  97. Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope. Biomaterials. 2012 Sep; 33(27):6476-84.
    View in: PubMed
    Score: 0.009
  98. Modulating adaptive immune responses to peptide self-assemblies. ACS Nano. 2012 Feb 28; 6(2):1557-64.
    View in: PubMed
    Score: 0.008
  99. TLR signals promote IL-6/IL-17-dependent transplant rejection. J Immunol. 2009 May 15; 182(10):6217-25.
    View in: PubMed
    Score: 0.007
  100. The Mll partial tandem duplication: differential, tissue-specific activity in the presence or absence of the wild-type allele. Blood. 2008 Sep 15; 112(6):2508-11.
    View in: PubMed
    Score: 0.007
  101. CD4+ T cells are sufficient to elicit allograft rejection and major histocompatibility complex class I molecule is required to induce recurrent autoimmune diabetes after pancreas transplantation in mice. Transplantation. 2008 Apr 27; 85(8):1205-11.
    View in: PubMed
    Score: 0.006
  102. Bioluminescence imaging visualizes activation of nuclear factor-kappaB in mouse cardiac transplantation. Transplantation. 2008 Mar 27; 85(6):903-10.
    View in: PubMed
    Score: 0.006
  103. Cell surface receptors for sulphated polysaccharides: a potential marker for macrophage subsets. Immunology. 1986 Jun; 58(2):277-84.
    View in: PubMed
    Score: 0.006
  104. Nonimmune lymphocyte-macrophage interaction. I. Quantification by an automated colorimetric assay. Cell Immunol. 1985 May; 92(2):265-76.
    View in: PubMed
    Score: 0.005
  105. Nonimmune lymphocyte-macrophage interaction. II. Evidence that the interaction involves sulfated polysaccharide recognition. Cell Immunol. 1985 May; 92(2):277-89.
    View in: PubMed
    Score: 0.005
  106. Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J Exp Med. 2005 Mar 07; 201(5):779-91.
    View in: PubMed
    Score: 0.005
  107. Cutting edge: Cbl-b: one of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation. J Immunol. 2004 Dec 15; 173(12):7135-9.
    View in: PubMed
    Score: 0.005
  108. A mouse model for studying intrahepatic islet transplantation. Transplantation. 2004 Aug 27; 78(4):615-8.
    View in: PubMed
    Score: 0.005
  109. Evidence that tilapia islets do not express alpha-(1,3)gal: implications for islet xenotransplantation. Xenotransplantation. 2004 May; 11(3):276-83.
    View in: PubMed
    Score: 0.005
  110. Mouse-heart grafts expressing an incompatible carbohydrate antigen. II. Transition from accommodation to tolerance. Transplantation. 2004 Feb 15; 77(3):366-73.
    View in: PubMed
    Score: 0.005
  111. Direct killing of xenograft cells by CD8+ T cells of discordant xenograft recipients. Transplantation. 2002 Dec 15; 74(11):1587-95.
    View in: PubMed
    Score: 0.004
  112. Development and characterization of anti-Gal B cell receptor transgenic Gal-/- mice. Transplantation. 2002 May 27; 73(10):1549-57.
    View in: PubMed
    Score: 0.004
  113. The structure of anti-Gal immunoglobulin genes in naïve and stimulated Gal knockout mice. Transplantation. 2001 Dec 15; 72(11):1817-25.
    View in: PubMed
    Score: 0.004
  114. Activation of extracellular signal-regulated kinases potentiates hemin toxicity in astrocyte cultures. J Neurochem. 2001 Nov; 79(3):545-55.
    View in: PubMed
    Score: 0.004
  115. Onset of accumulation of PrPres in murine ME7 scrapie in relation to pathological and PrP immunohistochemical changes. J Comp Pathol. 2001 Jan; 124(1):20-8.
    View in: PubMed
    Score: 0.004
  116. Differential immune response to carbohydrate epitopes on allo- and xenografts: implications for accommodation. Transplant Proc. 2000 Aug; 32(5):991-3.
    View in: PubMed
    Score: 0.004
  117. Differential immune responses to alpha-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation. J Clin Invest. 2000 Feb; 105(3):301-10.
    View in: PubMed
    Score: 0.004
  118. Immunosuppression preventing concordant xenogeneic islet graft rejection is not sufficient to prevent recurrence of autoimmune diabetes in nonobese diabetic mice. Transplantation. 1998 May 27; 65(10):1310-4.
    View in: PubMed
    Score: 0.003
  119. Differential effect of leflunomide on concordant xenogeneic islet graft rejection and recurrence of autoimmune diabetes. Transplant Proc. 1998 Mar; 30(2):463-4.
    View in: PubMed
    Score: 0.003
  120. Leflunomide-based immunosuppression for porcine islet xenotransplantation. Transplant Proc. 1998 Mar; 30(2):515.
    View in: PubMed
    Score: 0.003
  121. Effect of gene gun-mediated CTLA4IG and Fas ligand gene transfection on concordant xenogeneic islet graft rejection. Transplant Proc. 1998 Mar; 30(2):589.
    View in: PubMed
    Score: 0.003
  122. Inhibition of JAK3 and STAT6 tyrosine phosphorylation by the immunosuppressive drug leflunomide leads to a block in IgG1 production. J Immunol. 1998 Feb 15; 160(4):1581-8.
    View in: PubMed
    Score: 0.003
  123. Effect of leflunomide and cyclosporine on concordant xenogeneic islet transplantation in streptozotocin-induced and autoimmune diabetic mice. Transplant Proc. 1997 Jun; 29(4):2155.
    View in: PubMed
    Score: 0.003
  124. Successful xenotransplantation of adult porcine islets in NOD and BALB/c mice with leflunomide and cyclosporine. Transplant Proc. 1997 Jun; 29(4):2166-7.
    View in: PubMed
    Score: 0.003
  125. Gene gun-mediated gene transfer and expression in rat islets. Transplant Proc. 1997 Jun; 29(4):2209-10.
    View in: PubMed
    Score: 0.003
  126. Cytotoxicity of prion protein peptide (PrP106-126) differs in mechanism from the cytotoxic activity of the Alzheimer's disease amyloid peptide, A beta 25-35. Neurodegeneration. 1996 Mar; 5(1):1-11.
    View in: PubMed
    Score: 0.003
  127. Regulation of B cell function by the immunosuppressive agent leflunomide. Transplantation. 1996 Feb 27; 61(4):635-42.
    View in: PubMed
    Score: 0.003
  128. Evidence for a dithiol-activated signaling pathway in natural killer cell avidity regulation of leukocyte function antigen-1: structural requirements and relationship to phorbol ester- and CD16-triggered pathways. Blood. 1995 Sep 15; 86(6):2288-301.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.